| RHYTHM PHARMACEUTICALS |
| USA |
| Gesundheit |
| US76243J1051 / A2H5A0 |
| 1RV (Frankfurt) / RYTM (NASDAQ) |
| FRA:1RV, ETR:1RV, 1RV:GR, NASDAQ:RYTM |
| - |
| https://www.rhythmtx.com/ |
|
Rhythm Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuroendocrine diseases, particularly those involving hyperphag..
>Volltext.. |
| 5591.4 Mio. EUR |
| 5466.26 Mio. EUR |
| 163.66 Mio. EUR |
| -164.45 Mio. EUR |
| -169.51 Mio. EUR |
| -2.68 EUR |
| 209.69 Mio. EUR |
| 46.83 Mio. EUR |
| -99.77 Mio. EUR |
| 3.67 |
| 28.53% |
| 33.52% |
| - |
| - |
| - |
| RHYTHM PHARMACEUTICALS, RHYTHM PHARMA, RHYTHM PHARMACEUTICAL |
| 04.03.26 |
|